Regeneron Pharmaceuticals, Inc. (REGN) operating KPIs
REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 17/309% above fair value
$927.89+109.12 (+13.33%)
Close on Oct 30, 2026Market cap $95.53BP/E 20.5Yield –
KPIs
Operating metrics that drive Regeneron Pharmaceuticals's business
Coming soon
This tab will track the numbers specific to Regeneron Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.